The involvement of glycosaminoglycans in airway disease associated with cystic fibrosis

TheScientificWorldJournal

Volumn 11, Issue , 2011, Pages 959-971

  Reeves, Emer P ^a   Bergin, David A ^a   Murray, Michelle A ^a   McElvaney, Noel G ^a  

^a BEAUMONT HOSPITAL   (Ireland)

Author keywords

Airway inflammatory disease; Cystic fibrosis; Glycosaminoglycans; Neutrophil antimicrobial peptides and proteases

Indexed keywords

BETA DEFENSIN 2; CHONDROITIN SULFATE; GLYCOSAMINOGLYCAN; HEPARAN SULFATE; HYALURONIC ACID; PROTEINASE;

CYSTIC FIBROSIS; DISEASE ASSOCIATION; ENZYME ACTIVITY; GENE EXPRESSION; HUMAN; INFLAMMATION; NEUTROPHIL; NONHUMAN; RESPIRATORY TRACT DISEASE; SHORT SURVEY;

CYSTIC FIBROSIS; EXTRACELLULAR MATRIX; GLYCOSAMINOGLYCANS; HUMANS; PEPTIDE HYDROLASES; RESPIRATION DISORDERS; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

EID: 79958171038     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1100/tsw.2011.81     Document Type: Short Survey

References (129)

1. McElvaney, N.G., Hubbard, R.C., Birrer, P., Chernick, M.S., Caplan, D.B., Frank, M.M., and Crystal, R.G. (1991) Aerosol alpha 1-antitrypsin treatment for cystic fibrosis. Lancet 337, 392-394.
2. Balough, K., McCubbin, M., Weinberger, M., Smits, W., Ahrens, R., and Fick, R. (1995) The relationship between infection and inflammation in the early stages of lung disease from cystic fibrosis. Pediatr. Pulmonol. 20, 63-70.
3. Wilmott, R.W., Kassab, J.T., Kilian, P.L., Benjamin, W.R., Douglas, S.D., and Wood, R.E. (1990) Increased levels of interleukin-1 in bronchoalveolar washings from children with bacterial pulmonary infections. Am. Rev. Respir. Dis. 142, 365-368. (Pubitemid 20235946)
4. Tirouvanziam, R., de Bentzmann, S., Hubeau, C., Hinnrasky, J., Jacquot, J., Peault, B., and Puchelle, E. (2000) Inflammation and infection in naive human cystic fibrosis airway grafts. Am. J. Respir. Cell Mol. Biol. 23, 121-127. (Pubitemid 30656417)
5. Khan, T.Z., Wagener, J.S., Bost, T., Martinez, J., Accurso, F.J., and Riches, D.W. (1995) Early pulmonary inflammation in infants with cystic fibrosis. Am. J. Respir. Crit. Care Med. 151, 1075-1082.
6. Guilbault, C., Saeed, Z., Downey, G.P., and Radzioch, D. (2007) Cystic fibrosis mouse models. Am. J. Respir. Cell Mol. Biol. 36, 1-7. (Pubitemid 46067701)
7. Joo, N.S., Cho, H.J., Khansaheb, M., and Wine, J.J. (2010) Hyposecretion of fluid from tracheal submucosal glands of CFTR-deficient pigs. J. Clin. Invest. 120, 3161-3166.
8. Sun, X. et al. (2010) Disease phenotype of a ferret CFTR-knockout model of cystic fibrosis. J. Clin. Invest. 120, 3149-3160.
9. Stoltz, D.A. et al. (2010) Cystic fibrosis pigs develop lung disease and exhibit defective bacterial eradication at birth. Sci. Transl. Med. 2, 29-31.
10. Muhlebach, M.S., Stewart, P.W., Leigh, M.W., and Noah, T.L. (1999) Quantitation of inflammatory responses to bacteria in young cystic fibrosis and control patients. Am. J. Respir. Crit. Care Med. 160, 186-191. (Pubitemid 29326086)
11. Muhlebach, M.S. and Noah, T.L. (2002) Endotoxin activity and inflammatory markers in the airways of young patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. 165, 911-915. (Pubitemid 34774656)
12. Seeberger, P.H. and Werz, D.B. (2007) Synthesis and medical applications of oligosaccharides. Nature 446, 1046-1051. (Pubitemid 46676067)
13. Negrini, D., De Luca, G., Passi, A., and Miserocchi, G. (2002) Matrix proteoglycans in development of pulmonary edema. In Proteoglycans in Lung Disease. Garg, H.G., Roughley, P.J., and Hales, C.A., Eds. Marcel Dekker. New York. pp. 143-168.
14. Suki, B., Ito, S., Stamenovic, D., Lutchen, K.R., and Ingenito, E.P. (2005) Biomechanics of the lung parenchyma: critical roles of collagen and mechanical forces. J. Appl. Physiol. 98, 1892-1899. (Pubitemid 40570805)
15. Proudfoot, A.E. et al. (2003) Glycosaminoglycan binding and oligomerization are essential for the in vivo activity of certain chemokines. Proc. Natl. Acad. Sci. U. S. A. 100, 1885-1890. (Pubitemid 36254543)
16. Sadir, R., Forest, E., and Lortat-Jacob, H. (1998) The heparan sulfate binding sequence of interferon-gamma increased the on rate of the interferon-gamma-interferon-gamma receptor complex formation. J. Biol. Chem. 273, 10919-10925. (Pubitemid 28204930)
17. Lortat-Jacob, H. and Grimaud, J.A. (1991) Interferon-gamma binds to heparan sulfate by a cluster of amino acids located in the C-terminal part of the molecule. FEBS Lett. 280, 152-154.
18. Lortat-Jacob, H., Baltzer, F., and Grimaud, J.A. (1996) Heparin decreases the blood clearance of interferon-gamma and increases its activity by limiting the processing of its carboxyl-terminal sequence. J. Biol. Chem. 271, 16139-16143. (Pubitemid 26236230)
19. Forteza, R., Lauredo, I., Abraham, W.M., and Conner, G.E. (1999) Bronchial tissue kallikrein activity is regulated by hyaluronic acid binding. Am. J. Respir. Cell Mol. Biol. 21, 666-74. (Pubitemid 129502285)
20. Lieb, T., Forteza, R., and Salathe, M. (2000) Hyaluronic acid in cultured ovine tracheal cells and its effect on ciliary beat frequency in vitro. J. Aerosol Med. 13, 231-237.
21. Marquezini, M.V., Strunz, C.M., Dallan, L.A., and Toledo, O.M. (1995) Glycosaminoglycan distribution in atherosclerotic saphenous vein grafts. Cardiology 86, 143-146.
22. Bhaskar, K.R., Turner, B.S., Grubman, S.A., Jefferson, D.M., and LaMont, J.T. (1998) Dysregulation of proteoglycan production by intrahepatic biliary epithelial cells bearing defective (delta-f508) cystic fibrosis transmembrane conductance regulator. Hepatology 27, 7-14. (Pubitemid 28041527)
23. Hilliard, T.N., Regamey, N., Shute, J.K., Nicholson, A.G., Alton, E.W., Bush, A., and Davies, J.C. (2007) Airway remodelling in children with cystic fibrosis. Thorax 62, 1074-1080. (Pubitemid 350206200)
24. Solic, N., Wilson, J., Wilson, S.J., and Shute, J.K. (2005) Endothelial activation and increased heparan sulfate expression in cystic fibrosis. Am. J. Respir. Crit. Care Med. 172, 892-898. (Pubitemid 41369074)
25. Khatri, I.A., Bhaskar, K.R., Lamont, J.T., Sajjan, S.U., Ho, C.K., and Forstner, J. (2003) Effect of chondroitinase ABC on purulent sputum from cystic fibrosis and other patients. Pediatr. Res. 53, 619-627. (Pubitemid 36406732)
26. Rahmoune, H., Lamblin, G., Lafitte, J.J., Galabert, C., Filliat, M., and Roussel, P. (1991) Chondroitin sulfate in sputum from patients with cystic fibrosis and chronic bronchitis. Am. J. Respir. Cell Mol. Biol. 5, 315-320.
27. Sahu, S.C. (1980) Hyaluronic acid. An indicator of pathological conditions of human lungs? Inflammation 4, 107-112.
28. Wyatt, H.A., Dhawan, A., Cheeseman, P., Mieli-Vergani, G., and Price, J.F. (2002) Serum hyaluronic acid concentrations are increased in cystic fibrosis patients with liver disease. Arch. Dis. Child. 86, 190-193. (Pubitemid 34250864)
29. Petrigni, G. and Allegra, L. (2006) Aerosolised hyaluronic acid prevents exercise-induced bronchoconstriction, suggesting novel hypotheses on the correction of matrix defects in asthma. Pulm. Pharmacol. Ther. 19, 166-171.
30. Nettelbladt, O., Tengblad, A., and Hallgren, R. (1989) Lung accumulation of hyaluronan parallels pulmonary edema in experimental alveolitis. Am. J. Physiol. 257, L379-384.
31. Turino, G.M. and Cantor, J.O. (2003) Hyaluronan in respiratory injury and repair. Am. J. Respir. Crit. Care Med. 167, 1169-1175. (Pubitemid 36555086)
32. Baccarani-Contri, M., Vincenzi, D., Cicchetti, F., Mori, G., and Pasquali-Ronchetti, I. (1990) Immunocytochemical localization of proteoglycans within normal elastin fibers. Eur. J. Cell Biol. 53, 305-312.
33. Kielty, C.M., Whittaker, S.P., Grant, M.E., and Shuttleworth, C.A. (1992) Type VI collagen microfibrils: evidence for a structural association with hyaluronan. J. Cell Biol. 118, 979-990.
34. Toole, B.P. (1990) Hyaluronan and its binding proteins, the hyaladherins. Curr. Opin. Cell Biol. 2, 839-44.
35. Teder, P., Vandivier, R.W., Jiang, D., Liang, J., Cohn, L., Pure, E., Henson, P.M., and Noble, P.W. (2002) Resolution of lung inflammation by CD44. Science 296, 155-158. (Pubitemid 34280077)
36. Savani, R.C. et al. (1995) Migration of bovine aortic smooth muscle cells after wounding injury. The role of hyaluronan and RHAMM. J. Clin. Invest. 95, 1158-1168.
37. Jiang, D. et al. (2005) Regulation of lung injury and repair by Toll-like receptors and hyaluronan. Nat. Med. 11, 1173-1179. (Pubitemid 43093664)
38. Taylor, K.R., Yamasaki, K., Radek, K.A., Di Nardo, A., Goodarzi, H., Golenbock, D., Beutler, B., and Gallo, R.L. (2007) Recognition of hyaluronan released in sterile injury involves a unique receptor complex dependent on Toll-like receptor 4, CD44, and MD-2. J. Biol. Chem. 282, 18265-18275. (Pubitemid 47100227)
39. Fieber, C. et al. (2004) Hyaluronan-oligosaccharide-induced transcription of metalloproteases. J. Cell Sci. 117, 359-367. (Pubitemid 38128913)
40. Khaldoyanidi, S., Moll, J., Karakhanova, S., Herrlich, P., and Ponta, H. (1999) Hyaluronate-enhanced hematopoiesis: two different receptors trigger the release of interleukin-1beta and interleukin-6 from bone marrow macrophages. Blood 94, 940-949. (Pubitemid 29361825)
41. Itano, N. et al. (1999) Three isoforms of mammalian hyaluronan synthases have distinct enzymatic properties. J. Biol. Chem. 274, 25085-25092.
42. Horton, M.R., Boodoo, S., and Powell, J.D. (2002) NF-kappa B activation mediates the cross-talk between extracellular matrix and interferon-gamma (IFN-gamma) leading to enhanced monokine induced by IFN-gamma (MIG) expression in macrophages. J. Biol. Chem. 277, 43757-43762. (Pubitemid 36157794)
43. Cantor, J.O., Cerreta, J.M., Armand, G., and Turino, G.M. (1998) Aerosolized hyaluronic acid decreases alveolar injury induced by human neutrophil elastase. Proc. Soc. Exp. Biol. Med. 217, 471-475.
44. Chen, W.Y. and Abatangelo, G. (1999) Functions of hyaluronan in wound repair. Wound Repair Regen. 7, 79-89. (Pubitemid 29200045)
45. Graf, J., Neusel, E., Schneider, E., and Niethard, F.U. (1993) Intra-articular treatment with hyaluronic acid in osteoarthritis of the knee joint: a controlled clinical trial versus mucopolysaccharide polysulfuric acid ester. Clin. Exp. Rheumatol. 11, 367-372. (Pubitemid 23287156)
46. Schulz, T., Schumacher, U., Prante, C., Sextro, W., and Prehm, P. (2010) Cystic fibrosis transmembrane conductance regulator can export hyaluronan. Pathobiology 77, 200-209.
47. Okada, Y., Maeno, E., and Mori, S. (2004) Anion channel involved in induction of apoptosis and necrosis. Adv. Exp. Med. Biol. 559, 205-209.
48. Handel, T.M., Johnson, Z., Crown, S.E., Lau, E.K., and Proudfoot, A.E. (2005) Regulation of protein function by glycosaminoglycans - as exemplified by chemokines. Annu. Rev. Biochem. 74, 385-410. (Pubitemid 40995512)
49. LeBaron, R.G., Höök, A., Esko, J.D., Gay, S., and Höök, M. (1989) Binding of heparan sulfate to type V collagen. A mechanism of cell-substrate adhesion. J. Biol. Chem. 264, 7950-7956. (Pubitemid 19137273)
50. Whitelock, J.M. and Iozzo, R.V. (2005) Heparan sulfate: a complex polymer charged with biological activity. Chem. Rev. 105, 2745-2764. (Pubitemid 41055329)
51. Lipscombe, R.J., Nakhoul, A.M., Sanderson, C.J., and Coombe, D.R. (1998) Interleukin-5 binds to heparin/heparan sulfate. A model for an interaction with extracellular matrix. J. Leukoc. Biol. 63, 342-350. (Pubitemid 28106848)
52. Menart, V., Fonda, I., Kenig, M., and Porekar, V.G. (2002) Increased in vitro cytotoxicity of TNF-alpha analog LK-805 is based on the interaction with cell surface heparan sulfate proteoglycan. Ann. N. Y. Acad. Sci. 973, 194-206. (Pubitemid 36125003)
53. Mummery, R.S. and Rider, C.C. (2000) Characterization of the heparin-binding properties of IL-6. J. Immunol. 165, 5671-5679.
54. Goger, B., Halden, Y., Rek, A., Mosl, R., Pye, D., Gallagher, J., and Kungl, A.J. (2002) Different affinities of glycosaminoglycan oligosaccharides for monomeric and dimeric interleukin-8: a model for chemokine regulation at inflammatory sites. Biochemistry 41, 1640-1646. (Pubitemid 34112754)
55. Marshall, L.J., Ramdin, L.S., Brooks, T., DPhil, P.C., and Shute, J.K. (2003) Plasminogen activator inhibitor-1 supports IL-8-mediated neutrophil transendothelial migration by inhibition of the constitutive shedding of endothelial IL-8/heparan sulfate/syndecan-1 complexes. J. Immunol. 171, 2057-2065. (Pubitemid 36966489)
56. Kuschert, G.S., Coulin, F., Power, C.A., Proudfoot, A.E., Hubbard, R.E., Hoogewerf, A.J., and Wells, T.N. (1999) Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry 38, 12959-12968.
57. Krieger, E., Geretti, E., Brandner, B., Goger, B., Wells, T.N., and Kungl, A.J. (2004) A structural and dynamic model for the interaction of interleukin-8 and glycosaminoglycans: support from isothermal fluorescence titrations. Proteins 54, 768-775. (Pubitemid 38298795)
58. Rapraeger, A.C., Krufka, A., and Olwin, B.B. (1991) Requirement of heparan sulfate for bFGF-mediated fibroblast growth and myoblast differentiation. Science 252, 1705-1708. (Pubitemid 21917092)
59. Reeves, E.P. et al. (2010) IL-8 dictates glycosaminoglycan binding and stability of IL-18 in cystic fibrosis. J. Immunol. 184, 1642-1652.
60. Frevert, C.W. et al. (2002) Tissue-specific mechanisms control the retention of IL-8 in lungs and skin. J. Immunol. 168, 3550-3556. (Pubitemid 34250424)
61. Kelly, E., Greene, C.M., and McElvaney, N.G. (2008) Targeting neutrophil elastase in cystic fibrosis. Expert Opin. Ther. Targets 12, 145-157. (Pubitemid 351284958)
62. Plotkowski, M.C., Costa, A.O., Morandi, V., Barbosa, H.S., Nader, H.B., de Bentzmann, S., and Puchelle, E. (2001) Role of heparan sulphate proteoglycans as potential receptors for non-piliated Pseudomonas aeruginosa adherence to non-polarised airway epithelial cells. J. Med. Microbiol. 50, 183-190. (Pubitemid 32113169)
63. Deepa, S.S., Umehara, Y., Higashiyama, S., Itoh, N., and Sugahara, K. (2002) Specific molecular interactions of oversulfated chondroitin sulfate E with various heparin-binding growth factors. Implications as a physiological binding partner in the brain and other tissues. J. Biol. Chem. 277, 43707-43716. (Pubitemid 36157787)
64. Kawashima, H., Atarashi, K., Hirose, M., Hirose, J., Yamada, S., Sugahara, K., and Miyasaka, M. (2002) Oversulfated chondroitin/dermatan sulfates containing GlcAbeta1/IdoAalpha1-3GalNAc(4,6-O-disulfate) interact with L- and P-selectin and chemokines. J. Biol. Chem. 277, 12921-12930. (Pubitemid 34952659)
65. Tiedemann, K., Olander, B., Eklund, E., Todorova, L., Bengtsson, M., Maccarana, M., Westergren-Thorsson, G., and Malmstrom, A. (2005) Regulation of the chondroitin/dermatan fine structure by transforming growth factor-beta1 through effects on polymer-modifying enzymes. Glycobiology 15, 1277-1285. (Pubitemid 41724332)
66. Frates, R.C., Jr., Kaizu, T.T., and Last, J.A. (1983) Mucus glycoproteins secreted by respiratory epithelial tissue from cystic fibrosis patients. Pediatr. Res. 17, 30-34. (Pubitemid 13223450)
67. Cheng, P.W., Boat, T.F., Cranfill, K., Yankaskas, J.R., and Boucher, R.C. (1989) Increased sulfation of glycoconjugates by cultured nasal epithelial cells from patients with cystic fibrosis. J. Clin. Invest. 84, 68-72. (Pubitemid 19170096)
68. Mohapatra, N.K., Cheng, P.W., Parker, J.C., Paradiso, A.M., Yankaskas, J.R., Boucher, R.C., and Boat, T.F. (1995) Alteration of sulfation of glycoconjugates, but not sulfate transport and intracellular inorganic sulfate content in cystic fibrosis airway epithelial cells. Pediatr. Res. 38, 42-48.
69. Hill, W.G., Harper, G.S., Rozaklis, T., Boucher, R.C., and Hopwood, J.J. (1997) Organ-specific over-sulfation of glycosaminoglycans and altered extracellular matrix in a mouse model of cystic fibrosis. Biochem. Mol. Med. 62, 113-122. (Pubitemid 27495289)
70. Boat, T.F., Cheng, P.W., Iyer, R.N., Carlson, D.M., and Polony, I. (1976) Human respiratory tract secretion. Mucous glycoproteins of nonpurulent tracheobronchial secretions, and sputum of patients with bronchitis and cystic fibrosis. Arch. Biochem. Biophys. 177, 95-104.
71. Beratis, N.G., Turner, B.M., Weiss, R., and Hirschhorn, K. (1975) Arylsulfatase B deficiency in Maroteaux-Lamy syndrome: cellular studies and carrier identification. Pediatr. Res. 9, 475-480.
72. Tobacman, J.K. (2003) Does deficiency of arylsulfatase B have a role in cystic fibrosis? Chest 123, 2130-2139.
73. Bhattacharyya, S., Solakyildirim, K., Zhang, Z., Chen, M.L., Linhardt, R.J., and Tobacman, J.K. (2009) Cell-bound IL-8 increases in bronchial epithelial cells after arylsulfatase B silencing due to sequestration with chondroitin-4-sulfate. Am. J. Respir. Cell Mol. Biol. 42, 51-61.
74. Bhattacharyya, S., Look, D., and Tobacman, J.K. (2007) Increased arylsulfatase B activity in cystic fibrosis cells following correction of CFTR. Clin. Chim. Acta 380, 122-127. (Pubitemid 46498042)
75. Arteel, G.E., Franken, S., Kappler, J., and Sies, H. (2000) Binding of selenoprotein P to heparin: characterization with surface plasmon resonance. Biol. Chem. 381, 265-268. (Pubitemid 30179561)
76. Gandhi, N.S., Coombe, D.R., and Mancera, R.L. (2008) Platelet endothelial cell adhesion molecule 1 (PECAM-1) and its interactions with glycosaminoglycans: 1. Molecular modeling studies. Biochemistry 47, 4851-4862. (Pubitemid 351574992)
77. Newport, S., Amin, N., and Dozor, A.J. (2009) Exhaled breath condensate pH and ammonia in cystic fibrosis and response to treatment of acute pulmonary exacerbations. Pediatr. Pulmonol. 44, 866-872.
78. Tate, S., MacGregor, G., Davis, M., Innes, J.A., and Greening, A.P. (2002) Airways in cystic fibrosis are acidified: detection by exhaled breath condensate. Thorax 57, 926-929. (Pubitemid 35316268)
79. Birrer, P., McElvaney, N.G., Rudeberg, A., Sommer, C.W., Liechti-Gallati, S., Kraemer, R., Hubbard, R., and Crystal, R.G. (1994) Protease-antiprotease imbalance in the lungs of children with cystic fibrosis. Am. J. Respir. Crit. Care Med. 150, 207-213. (Pubitemid 24209960)
80. Nakamura, H., Yoshimura, K., McElvaney, N.G., and Crystal, R.G. (1992) Neutrophil elastase in respiratory epithelial lining fluid of individuals with cystic fibrosis induces interleukin-8 gene expression in a human bronchial epithelial cell line. J. Clin. Invest. 89, 1478-1484.
81. Damiano, V.V., Tsang, A., Kucich, U., Abrams, W.R., Rosenbloom, J., Kimbel, P., Fallahnejad, M., and Weinbaum, G. (1986) Immunolocalization of elastase in human emphysematous lungs. J. Clin. Invest. 78, 482-493. (Pubitemid 16074086)
82. Janoff, A. (1985) Elastase in tissue injury. Annu. Rev. Med. 36, 207-216.
83. Klebanoff, S.J., Kinsella, M.G., and Wight, T.N. (1993) Degradation of endothelial cell matrix heparan sulfate proteoglycan by elastase and the myeloperoxidase-H2O2-chloride system. Am. J. Pathol. 143, 907-917. (Pubitemid 24058246)
84. Geraghty, P., Greene, C.M., O'Mahony, M., O'Neill, S.J., Taggart, C.C., and McElvaney, N.G. (2007) Secretory leucocyte protease inhibitor inhibits interferon-gamma-induced cathepsin S expression. J. Biol. Chem. 282, 33389-33395. (Pubitemid 350159551)
85. McElvaney, N.G., Doujaiji, B., Moan, M.J., Burnham, M.R., Wu, M.C., and Crystal, R.G. (1993) Pharmacokinetics of recombinant secretory leukoprotease inhibitor aerosolized to normals and individuals with cystic fibrosis. Am. Rev. Respir. Dis. 148, 1056-1060. (Pubitemid 23301230)
86. Martin, S.L., Downey, D., Bilton, D., Keogan, M.T., Edgar, J., and Elborn, J.S. (2006) Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis. Pediatr. Pulmonol. 41, 177-183. (Pubitemid 43165448)
87. Griese, M., Latzin, P., Kappler, M., Weckerle, K., Heinzlmaier, T., Bernhardt, T., and Hartl, D. (2007) Alpha1-antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients. Eur. Respir. J. 29, 240-250. (Pubitemid 46231900)
88. Baici, A., Diczhazi, C., Neszmelyi, A., Moczar, E., and Hornebeck, W. (1993) Inhibition of the human leukocyte endopeptidases elastase and cathepsin G and of porcine pancreatic elastase by N-oleoyl derivatives of heparin. Biochem. Pharmacol. 46, 1545-1549. (Pubitemid 23338486)
89. Fryer, A. et al. (1997) Selective O-desulfation produces nonanticoagulant heparin that retains pharmacological activity in the lung. J. Pharmacol. Exp. Ther. 282, 208-219. (Pubitemid 27425543)
90. Rao, N.V., Kennedy, T.P., Rao, G., Ky, N., and Hoidal, J.R. (1990) Sulfated polysaccharides prevent human leukocyte elastase-induced acute lung injury and emphysema in hamsters. Am. Rev. Respir. Dis. 142, 407-412. (Pubitemid 20235954)
91. Lafuma, C., Frisdal, E., Harf, A., Robert, L., and Hornebeck, W. (1991) Prevention of leucocyte elastase-induced emphysema in mice by heparin fragments. Eur. Respir. J. 4, 1004-1009.
92. Tian, Y., Gebitekin, C., Martin, P., Satur, C.M., Mearns, A., and Walker, D.R. (1995) Influence of heparin thromboprophylaxis on plasma leucocyte elastase levels following lobectomy for lung carcinoma. Blood Coagul. Fibrinolysis 6, 527-530.
93. Buczek-Thomas, J.A. and Nugent, M.A. (1999) Elastase-mediated release of heparan sulfate proteoglycans from pulmonary fibroblast cultures. A mechanism for basic fibroblast growth factor (bFGF) release and attenuation of bfgf binding following elastase-induced injury. J. Biol. Chem. 274, 25167-25172.
94. van de Lest, C.H., Versteeg, E.M., Veerkamp, J.H., and van Kuppevelt, T.H. (1995) Digestion of proteoglycans in porcine pancreatic elastase-induced emphysema in rats. Eur. Respir. J. 8, 238-245.
95. Spencer, J.L., Stone, P.J., and Nugent, M.A. (2006) New insights into the inhibition of human neutrophil elastase by heparin. Biochemistry 45, 9104-9120. (Pubitemid 44156373)
96. Walsh, R.L., Dillon, T.J., Scicchitano, R., and McLennan, G. (1991) Heparin and heparan sulphate are inhibitors of human leucocyte elastase. Clin. Sci. (Lond.) 81, 341-346.
97. Volpi, N. (1996) Inhibition of human leukocyte elastase activity by heparins: influence of charge density. Biochim. Biophys. Acta 1290, 299-307.
98. Becker, M., Franz, G., and Alban, S. (2003) Inhibition of PMN-elastase activity by semisynthetic glucan sulfates. Thromb. Haemost. 89, 915-925. (Pubitemid 36608876)
99. Sissi, C., Lucatello, L., Naggi, A., Torri, G., and Palumbo, M. (2006) Interactions of low-molecular-weight semi-synthetic sulfated heparins with human leukocyte elastase and human cathepsin G. Biochem. Pharmacol. 71, 287-93. (Pubitemid 41817289)
100. Ledoux, D., Merciris, D., Barritault, D., and Caruelle, J.P. (2003) Heparin-like dextran derivatives as well as glycosaminoglycans inhibit the enzymatic activity of human cathepsin G. FEBS Lett. 537, 23-29. (Pubitemid 36246670)
101. Ying, Q.L., Kemme, M., Saunders, D., and Simon, S.R. (1997) Glycosaminoglycans regulate elastase inhibition by oxidized secretory leukoprotease inhibitor. Am. J. Physiol. 272, L533-541.
102. Fath, M.A., Wu, X., Hileman, R.E., Linhardt, R.J., Kashem, M.A., Nelson, R.M., Wright, C.D., and Abraham, W.M. (1998) Interaction of secretory leukocyte protease inhibitor with heparin inhibits proteases involved in asthma. J. Biol. Chem. 273, 13563-13569. (Pubitemid 28268398)
103. Martin, S.L., Moffitt, K.L., McDowell, A., Greenan, C., Bright-Thomas, R.J., Jones, A.M., Webb, A.K., and Elborn, J.S. (2010) Association of airway cathepsin B and S with inflammation in cystic fibrosis. Pediatr. Pulmonol. 45, 860-868.
104. Kaneider, N.C., Djanani, A., and Wiedermann, C.J. (2007) Heparan sulfate proteoglycan-involving immunomodulation by cathelicidin antimicrobial peptides LL-37 and PR-39. TheScientificWorldJOURNAL 7, 1832-1838. (Pubitemid 350277600)
105. Xiao, W., Hsu, Y.P., Ishizaka, A., Kirikae, T., and Moss, R.B. (2005) Sputum cathelicidin, urokinase plasminogen activation system components, and cytokines discriminate cystic fibrosis, COPD, and asthma inflammation. Chest 128, 2316-2326. (Pubitemid 41507575)
106. Soong, L.B., Ganz, T., Ellison, A., and Caughey, G.H. (1997) Purification and characterization of defensins from cystic fibrosis sputum. Inflamm. Res. 46, 98-102.
107. Baranska-Rybak, W., Sonesson, A., Nowicki, R., and Schmidtchen, A. (2006) Glycosaminoglycans inhibit the antibacterial activity of LL-37 in biological fluids. J. Antimicrob. Chemother. 57, 260-265. (Pubitemid 43160167)
108. Bergsson, G. et al. (2009) LL-37 complexation with glycosaminoglycans in cystic fibrosis lungs inhibits antimicrobial activity, which can be restored by hypertonic saline. J. Immunol. 183, 543-551.
109. Griffin, S., Taggart, C.C., Greene, C.M., O'Neill, S., and McElvaney, N.G. (2003) Neutrophil elastase up-regulates human beta-defensin-2 expression in human bronchial epithelial cells. FEBS Lett. 546, 233-236. (Pubitemid 36782417)
110. MacRedmond, R., Greene, C., Taggart, C.C., McElvaney, N., and O'Neill, S. (2005) Respiratory epithelial cells require Toll-like receptor 4 for induction of human beta-defensin 2 by lipopolysaccharide. Respir. Res. 6, 116.
111. McCullough, B.J. et al. (2010) Binding a heparin derived disaccharide to defensin inspired peptides: insights to antimicrobial inhibition from gas-phase measurements. Phys. Chem. Chem. Phys. 12, 3589-3596.
112. Schmidtchen, A., Frick, I.M., and Bjorck, L. (2001) Dermatan sulphate is released by proteinases of common pathogenic bacteria and inactivates antibacterial alpha-defensin. Mol. Microbiol. 39, 708-713. (Pubitemid 32162156)
113. Seo, E.S. et al. (2010) Interaction of human beta-defensin 2 (HBD2) with glycosaminoglycans. Biochemistry 49, 10486-10495.
114. Johnson, Z., Proudfoot, A.E., and Handel, T.M. (2005) Interaction of chemokines and glycosaminoglycans: a new twist in the regulation of chemokine function with opportunities for therapeutic intervention. Cytokine Growth Factor Rev. 16, 625-636. (Pubitemid 41509199)
115. Spillmann, D.L. and Lindahl, U. (1994) Glycosamioglycan-protein interactions, a question of specificity. Curr. Opin. Struct. Biol. 4, 677-682.
116. Jin, L., Abrahams, J.P., Skinner, R., Petitou, M., Pike, R.N., and Carrell, R.W. (1997) The anticoagulant activation of antithrombin by heparin. Proc. Natl. Acad. Sci. U. S. A. 94, 14683-14688. (Pubitemid 28041434)
117. Lyon, M. and Gallagher, J.T. (1998) Bio-specific sequences and domains in heparan sulphate and the regulation of cell growth and adhesion. Matrix Biol. 17, 485-493. (Pubitemid 28566883)
118. Suri, R. et al. (2001) Comparison of hypertonic saline and alternate-day or daily recombinant human deoxyribonuclease in children with cystic fibrosis: a randomised trial. Lancet 358, 1316-1321. (Pubitemid 33016495)
119. Fuchs, H.J. et al. (1994) Effect of aerosolized recombinant human DNase on exacerbations of respiratory symptoms and on pulmonary function in patients with cystic fibrosis. The Pulmozyme Study Group. N. Engl. J. Med. 331, 637-642. (Pubitemid 24276863)
120. King, M., Dasgupta, B., Tomkiewicz, R.P., and Brown, N.E. (1997) Rheology of cystic fibrosis sputum after in vitro treatment with hypertonic saline alone and in combination with recombinant human deoxyribonuclease I. Am. J. Respir. Crit. Care Med. 156, 173-177. (Pubitemid 27293184)
121. Rogers, D.F. (2007) Mucoactive agents for airway mucus hypersecretory diseases. Respir. Care 52, 1176-1193; discussion 1193-1197.
122. Reeves, E.P., Williamson, M., O'Neill, S.J., Greally, P., and McElvaney, N.G. (2011) Nebulised hypertonic saline decreases interleukin-8 in sputum of patients with cystic fibrosis. Am. J. Respir. Crit. Care Med. [Epub ahead of print]
123. Broughton-Head, V.J., Shur, J., Carroll, M.P., Smith, J.R., and Shute, J.K. (2007) Unfractionated heparin reduces the elasticity of sputum from patients with cystic fibrosis. Am. J. Physiol. Lung Cell. Mol. Physiol. 293, L1240-1249. (Pubitemid 350159408)
124. Shur, J., Nevell, T.G., Shute, J.K., and Smith, J.R. (2008) The spray drying of unfractionated heparin: optimization of the operating parameters. Drug Dev. Ind. Pharm. 34, 559-568. (Pubitemid 351878680)
125. Tang, J.X., Wen, Q., Bennett, A., Kim, B., Sheils, C.A., Bucki, R., and Janmey, P.A. (2005) Anionic poly(amino acid)s dissolve F-actin and DNA bundles, enhance DNase activity, and reduce the viscosity of cystic fibrosis sputum. Am. J. Physiol. Lung Cell. Mol. Physiol. 289, L599-605. (Pubitemid 41361670)
126. Serisier, D.J., Shute, J.K., Hockey, P.M., Higgins, B., Conway, J., and Carroll, M.P. (2006) Inhaled heparin in cystic fibrosis. Eur. Respir. J. 27, 354-358. (Pubitemid 43180914)
127. Douglas, M.S., Rix, D.A., Dark, J.H., Talbot, D., and Kirby, J.A. (1997) Examination of the mechanism by which heparin antagonizes activation of a model endothelium by interferon-gamma (IFN-gamma). Clin. Exp. Immunol. 107, 578-584. (Pubitemid 27102150)
128. Cripps, J.G., Crespo, F.A., Romanovskis, P., Spatola, A.F., and Fernandez-Botran, R. (2005) Modulation of acute inflammation by targeting glycosaminoglycan-cytokine interactions. Int. Immunopharmacol. 5, 1622-1632. (Pubitemid 41019433)
129. Jiang, D., Liang, J., and Noble, P.W. (2011) Hyaluronan as an immune regulator in human diseases. Physiol. Rev. 91, 221-264.